Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: * patients must be 18 years of age or older, of either gender * patients must be tested positive for sars-cov-2 by rt-pcr within 72 hours prior to enrolment * patients must exhibit typical symptoms of covid-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc. * patients must be in the early stage of covid-19 disease who do not require hospitalization at the time of screening * patients must be under the care of a physician for diagnosis of covid-19 * patients who have signed informed consent

inclusion criteria: * patients must be 18 years of age or older, of either gender * patients must be tested positive for sars-cov-2 by rt-pcr within 72 hours prior to enrolment * patients must exhibit typical symptoms of covid-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc. * patients must be in the early stage of covid-19 disease who do not require hospitalization at the time of screening * patients must be under the care of a physician for diagnosis of covid-19 * patients who have signed informed consent

March 27, 2022, 4 p.m. usa

inclusion criteria: patients must be 18 years of age or older, of either gender patients must be tested positive for sars-cov-2 by rt-pcr within 72 hours prior to enrolment patients must exhibit typical symptoms of covid-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc. patients must be in the early stage of covid-19 disease who do not require hospitalization at the time of screening patients must be under the care of a physician for diagnosis of covid-19 patients who have signed informed consent

inclusion criteria: patients must be 18 years of age or older, of either gender patients must be tested positive for sars-cov-2 by rt-pcr within 72 hours prior to enrolment patients must exhibit typical symptoms of covid-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc. patients must be in the early stage of covid-19 disease who do not require hospitalization at the time of screening patients must be under the care of a physician for diagnosis of covid-19 patients who have signed informed consent

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: sars-cov-2 infection confirmed by pcr. admitted in the hospital in the previous 48 hours, with clinical status 3, 4 or 5 of who classification. age above 18 years old. informed written consent.

inclusion criteria: sars-cov-2 infection confirmed by pcr. admitted in the hospital in the previous 48 hours, with clinical status 3, 4 or 5 of who classification. age above 18 years old. informed written consent.

Oct. 27, 2020, 11:31 p.m. usa

inclusion criteria: 1. sars-cov-2 infection confirmed by pcr. 2. admitted in the hospital in the previous 48 hours, with clinical status 3, 4 or 5 of who classification. 3. age above 18 years old. 4. informed written consent.

inclusion criteria: 1. sars-cov-2 infection confirmed by pcr. 2. admitted in the hospital in the previous 48 hours, with clinical status 3, 4 or 5 of who classification. 3. age above 18 years old. 4. informed written consent.